Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 1/20 | 0.61 |
| ▸ | CES1 | P23141 | 1/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.59 |
| ▸ | GAA | P10253 | 2/20 | 0.59 |
| ▸ | DBH | P09172 | 1/20 | 0.55 |
| ▸ | RECQL | P46063 | 1/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.52 |
| ▸ | HPGD | P15428 | 3/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | EGFR | P00533 | 1/20 | 0.52 |
| ▸ | TP53 | P04637 | 1/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | PKM | P14618 | 1/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.52 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.52 |
| ▸ | JAK1 | P23458 | 1/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16811768 | 0.94 | ALDH1A1 (0.54) | CES2CES1KDM4EALDH1A1GAA | |
| SCHEMBL12418686 | 0.92 | KDM4E (0.63) | CES2CES1KDM4EALDH1A1GAA | |
| SCHEMBL2599186 | 0.86 | CES2 (0.59) | CES2CES1KDM4EALDH1A1GAA | |
| SCHEMBL15007511 | 0.86 | CES2 (0.59) | CES2CES1KDM4EALDH1A1GAA | |
| SCHEMBL28100961 | 0.85 | ALDH1A1 (0.67) | CES2CES1KDM4EALDH1A1GAA | |
| SCHEMBL10458095 | 0.85 | KDM4E (0.52) | CES2CES1KDM4EALDH1A1GAA | |
| SCHEMBL9117029 | 0.85 | CES2 (0.57) | CES2CES1KDM4EALDH1A1GAA | |
| SCHEMBL5130655 | 0.85 | CES2 (0.57) | CES2CES1KDM4EALDH1A1GAA | |
| SCHEMBL2951738 | 0.85 | ALDH1A1 (0.62) | CES2CES1KDM4EALDH1A1GAA | |
| SCHEMBL6008182 | 0.85 | CES2 (0.57) | CES2CES1KDM4EALDH1A1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 83 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119504333-A | Preparation method and application of 2-methyl-6-alkyl naphthalene | 煤炭科学技术研究院有限公司 | 2025-02-25 | — | — | CN | disclosed |
| CN-222056389-U | 2-Methyl-6-propionyl naphthalene purification refining device | 品恩赢创(苏州)新材料科技有限公司 | 2024-11-26 | — | — | CN | disclosed |
| CN-222056389-U | 2-Methyl-6-propionyl naphthalene purification refining device | 品恩赢创(苏州)新材料科技有限公司 | 2024-11-26 | — | — | CN | disclosed |
| CN-118307394-A | Purification method of crude product of 2-methyl-6-propionylnaphthalene | 品恩赢创(苏州)新材料科技有限公司 | 2024-07-09 | — | — | CN | disclosed |
| US-20240207355-A1 | PHARMACEUTICAL COMPOSITION FOR ENHANCING ANTICANCER EFFECT OF ANTICANCER DRUG | L-Base Co., Ltd. (KR) | 2024-06-27 | — | — | US | disclosed |
| EP-3445812-B1 | REGIOSELECTIVELY SUBSTITUTED CELLULOSE ESTERS AND FILMS MADE THEREFROM | EASTMAN CHEM CO (US) | 2023-10-25 | — | — | EP | disclosed |
| US-20230235093-A1 | REGIOSELECTIVELY SUBSTITUTED CELLULOSE ESTERS AND FILMS MADE THEREFROM | EASTMAN CHEMICAL COMPANY (US) | 2023-07-27 | — | — | US | disclosed |
| US-20230159587-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER | L-Base Co., Ltd. (KR) | 2023-05-25 | — | — | US | disclosed |
| US-20230159587-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER | L-Base Co., Ltd. (KR) | 2023-05-25 | — | — | US | disclosed |
| US-11643477-B2 | Regioselectively substituted cellulose esters and films made therefrom | EASTMAN CHEMICAL COMPANY (US) | 2023-05-09 | — | — | US | disclosed |
| US-7169760-B2 | Peptides as NS3-serine protease inhibitors of hepatitis C virus | SCHERING CORPORATION (US) | 2007-01-30 | — | — | US | disclosed |
| CN-1817843-A | Production of 2-alkyl-6-acyl-naphthaline | HUADONG SCIENCE AND TECHNOLOGY (CN) | 2006-08-16 | — | — | CN | disclosed |
| WO-2006016708-A1 | FUNGICIDAL COMPOSITION CONTAINING ACID AMIDE DERIVATIVE | ISHIHARA SANGYO KAISHA, LTD. (JP) | 2006-02-16 | — | — | WO | disclosed |
| CN-1142928-C | Synthesis and use of retinoid compounds having negative hormone and/or antagonist activity | �ո��� | 2004-03-24 | — | — | CN | disclosed |
| CN-1121379-C | Synthesis and use of retinoid having negative hormone and/or antagonist activity | ALLERGAN CO (US) | 2003-09-17 | — | — | CN | disclosed |
| CN-1268130-A | Synthesis and use of retinol derivative compounds having negative hormone and/or antagonist activity | ALLERGAN SALES INC (US) | 2000-09-27 | — | — | CN | disclosed |
| CN-1209802-A | Synthesis and use of retinoid having negative hormone and/or antagonist activity | ALLERGAN CO (US) | 1999-03-03 | — | — | CN | disclosed |
| EP-0273647-B1 | COUMARAN DERIVATIVES, THEIR PRODUCTION AND USE | Takeda Chemical Industries, Ltd. (JP) | 1992-03-11 | — | — | EP | disclosed |
| US-4857516-A | Coumaran derivatives and their pharmaceutical use | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1989-08-15 | — | — | US | disclosed |
| EP-0273647-A1 | Coumaran derivatives, their production and use | Takeda Chemical Industries, Ltd. (JP) | 1988-07-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230159587-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER | VIP, QPCT, TPT1 | CES2 4869/4885CES1 3055/4885KDM4E 4144/4885 |
| US-20240207355-A1 | PHARMACEUTICAL COMPOSITION FOR ENHANCING ANTICANCER EFFECT OF ANTICANCER DRUG | ALPG, SLC11A2, SGTA | CES2 4879/4885CES1 4726/4885KDM4E 3119/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.